Veradermics, Incorporated
MANE
Jodie situation report
Veradermics, Incorporated's current read is isolated; its market group is not confirming.
No new filing conclusion is available. 0 of 1 group members are active now; 0 filing-linked outsiders are moving with the group, and 0 of 0 directly disclosed connections are confirming.
- VDPHL01 remains the main research and development spending driver, including clinical recruitment and medical education.
- Quarterly program spend on VDPHL01 increased materially in Q1 2026, driven by expanded registration-directed/confirmatory trial activity and recruitment costs.
Invalidation: The isolated read changes if MANE's group or a disclosed connection begins moving with it.
Who this business touches
The relationships behind MANE
Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.
Filing peers
Companies whose filings use similar operating language.
Open the three relationships above to see Jodie’s filing proof. Pro unlocks every receipt, and alerts when connected names begin moving. Unlock the full network →
What is moving around it
Live connections
MANE is currently a Leader in the organic co-movement group Dermatology Therapeutics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. No verified filing-linked names are available yet.
This group is retained as the last observed read for MANE; it is not active in the latest market snapshot.